Form 8-K - Current report:
SEC Accession No. 0001193125-25-265800
Filing Date
2025-11-05
Accepted
2025-11-05 08:00:41
Documents
49
Period of Report
2025-11-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nams-20251105.htm   iXBRL 8-K 62530
2 EX-99.1 nams-ex99_1.htm EX-99.1 705377
3 EX-99.2 nams-ex99_2.htm EX-99.2 51068
4 GRAPHIC nams-ex99_2s1.jpg GRAPHIC 347091
5 GRAPHIC nams-ex99_2s2.jpg GRAPHIC 951364
6 GRAPHIC nams-ex99_2s3.jpg GRAPHIC 479118
7 GRAPHIC nams-ex99_2s4.jpg GRAPHIC 306397
8 GRAPHIC nams-ex99_2s5.jpg GRAPHIC 346381
9 GRAPHIC nams-ex99_2s6.jpg GRAPHIC 152981
10 GRAPHIC nams-ex99_2s7.jpg GRAPHIC 209933
11 GRAPHIC nams-ex99_2s8.jpg GRAPHIC 517313
12 GRAPHIC nams-ex99_2s9.jpg GRAPHIC 364537
13 GRAPHIC nams-ex99_2s10.jpg GRAPHIC 327094
14 GRAPHIC nams-ex99_2s11.jpg GRAPHIC 298104
15 GRAPHIC nams-ex99_2s12.jpg GRAPHIC 327725
16 GRAPHIC nams-ex99_2s13.jpg GRAPHIC 350594
17 GRAPHIC nams-ex99_2s14.jpg GRAPHIC 289953
18 GRAPHIC nams-ex99_2s15.jpg GRAPHIC 375250
19 GRAPHIC nams-ex99_2s16.jpg GRAPHIC 341949
20 GRAPHIC nams-ex99_2s17.jpg GRAPHIC 337854
21 GRAPHIC nams-ex99_2s18.jpg GRAPHIC 241303
22 GRAPHIC nams-ex99_2s19.jpg GRAPHIC 239061
23 GRAPHIC nams-ex99_2s20.jpg GRAPHIC 403685
24 GRAPHIC nams-ex99_2s21.jpg GRAPHIC 310502
25 GRAPHIC nams-ex99_2s22.jpg GRAPHIC 332631
26 GRAPHIC nams-ex99_2s23.jpg GRAPHIC 457813
27 GRAPHIC nams-ex99_2s24.jpg GRAPHIC 327871
28 GRAPHIC nams-ex99_2s25.jpg GRAPHIC 407234
29 GRAPHIC nams-ex99_2s26.jpg GRAPHIC 321728
30 GRAPHIC nams-ex99_2s27.jpg GRAPHIC 313143
31 GRAPHIC nams-ex99_2s28.jpg GRAPHIC 312647
32 GRAPHIC nams-ex99_2s29.jpg GRAPHIC 414398
33 GRAPHIC nams-ex99_2s30.jpg GRAPHIC 369882
34 GRAPHIC nams-ex99_2s31.jpg GRAPHIC 305003
35 GRAPHIC nams-ex99_2s32.jpg GRAPHIC 442643
36 GRAPHIC nams-ex99_2s33.jpg GRAPHIC 349282
37 GRAPHIC nams-ex99_2s34.jpg GRAPHIC 358469
38 GRAPHIC nams-ex99_2s35.jpg GRAPHIC 301784
39 GRAPHIC nams-ex99_2s36.jpg GRAPHIC 332042
40 GRAPHIC nams-ex99_2s37.jpg GRAPHIC 293404
  Complete submission text file 0001193125-25-265800.txt   19139535

Data Files

Seq Description Document Type Size
41 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT nams-20251105.xsd EX-101.SCH 55020
51 EXTRACTED XBRL INSTANCE DOCUMENT nams-20251105_htm.xml XML 6274
Mailing Address GOOIMEER 2-35 NARRDEN P7 1411 DC
Business Address GOOIMEER 2-35 NARRDEN P7 1411 DC 35 206 2971
NewAmsterdam Pharma Co N.V. (Filer) CIK: 0001936258 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41562 | Film No.: 251451861
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)